Project Number PTC REG-20-652871 Agency/Funding Organization Alzheimer's Association Funding Year 2020 View Full Project Details for Repurposing nucleoside reverse transcriptase inhibitors for treatment of AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) h. Cell death Researcher and Organization Principal Investigator Sedivy, John M. Principal Investigator First Name John Principal Investigator Last Name Sedivy Awardee Organization BROWN UNIVERSITY Awardee State Rhode Island Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2020: PTC RFA FY Overall Cost $749,999 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Murtishaw, Andrew asmurtishaw@alz.org
